RxDoctor Payments Data

Heath Dreyfuss, MD

Otolaryngology · Mc Lean, VANPI 1205001898

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $12,620 of the $18,869 with a category attached, or 66.9%. Optinose US, Inc. accounts for 74.7% of it on its own, with 21 other manufacturers making up the rest. Among otolaryngology clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$18,869in general payments, 2019–2025

Across 246 payments — averaging $76.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Optinose US, Inc.$14K
  • Medtronic$1K
  • Regeneron Healthcare Solutions, Inc.$1K
  • Sanofi$633
  • Stryker$477
  • Acclarent, Inc$323
  • plus $1K from 16 others

What the payments were for

  • Speaking & faculty fees$12,62067%
  • Food & beverage$6,24933%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,869 in reported general payments places this provider in the 95th percentile of 241 otolaryngology providers in Virginia.

See all otolaryngology providers in Virginia

Medicare billing

Part B allowed, 2024
$224,422
Medicare patients
453
Services billed
3,197

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine-FluticasoneAzelastine/Fluticasone36$2,990
Ipratropium Bromide67$2,063
Azelastine Hcl19$553
Famotidine37$325
Omeprazole25$186
Fluticasone Propionate14$159
Methylprednisolone16$98
Cephalexin18$63
Montelukast Sodium11$47
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen21$40

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Mc Lean

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →